Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Monday, March 22, 2021

The HEAR Score

REBEL EM - March 22, 2021 - By Jonathan Gravel
Article: Smith LM et al. Identification of very low-risk acute chest pain patients without troponin testing. Emerg Med J 2020. PMID: 32753395.
“Clinical Question: When using the HEART Pathway to risk stratify patients, is there a group of very low-risk chest pain patients (HEAR score ≤ 1) that does not require troponin testing to achieve a MACE miss rate <1%?
Author Conclusion: These data suggest that patients with HEAR scores of 0 and 1 represent a very low-risk group that may not require troponin testing to achieve a missed MACE rate <1%”
Clinical Take Home Point: Using a HEAR score ≤1 without troponin testing to safely disposition patients is certainly interesting, has face validity, and worth validating. However, with 95% CI crossing >2% for MACE at 30d, I am not sure we are at a place where potentially missing this many events would be considered standard care or even safe from a medicolegal perspective.”